The Technical AnalystExchange: MIL Sector: Healthcare Industry: Drug Manufacturers—General
Recordati Industria Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.10% €50.75
America/New_York / 3 mai 2024 @ 11:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 10 455 mill |
| EPS: | 1.860 |
| P/E: | 27.28 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 206.01 mill |
| Avg Daily Volume: | 0.217 mill |
| RATING 2024-05-03 |
|---|
| S |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.06x |
| Company: PE 27.28 | sector: PE 25.67 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.02x |
| Company: PE 27.28 | industry: PE 26.62 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€80.42 (58.45%) €29.67 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
€ 49.80 - 51.70 ( +/- 1.88%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €50.75 (1.10% ) |
| Volume | 0.257 mill |
| Avg. Vol. | 0.217 mill |
| % of Avg. Vol | 118.39 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For REC.MI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
REC.MI
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.